Not Signed In -
Bicalutamide |
Casodex |
Image:Bicalutamide.png Bicalutamide Systematic (IUPAC) name N-[4-cyano-3-(trifluoromethyl)phenyl]- 3-(4-fluorophenyl)sulfonyl-2- hydroxy-2-methyl- propanamide Identifiers CAS number 90357-06-5 ATC code L02BB03 PubChem 56069 DrugBank APRD00042 Chemical data Formula C18H14F4N2O4S Mol. weight 430.374 g/mol Pharmacokinetic data Bioavailability ? Protein binding 96% Metabolism ? Half life 5.9 days Excretion ? Therapeutic considerations ...
Wikipedia - [full article]
Bicalutamide Clinical Trials
- Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis (BATT)]
ClinicalTrials.gov Identifier: NCT00094328 - Active, not recruiting
Puberty, Precocious
- Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00014586 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum
ClinicalTrials.gov Identifier: NCT00012090 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00031889 - Active, not recruiting
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00067015 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer; Quality of Life
- Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00021450 - Recruiting
stage II prostate cancer
- Pazopanib With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00486642 - Recruiting
Prostate Cancer
- Hormone Therapy in Treating Patients With Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003026 - Active, not recruiting
adenocarcinoma of the prostate
- Open Label,Phase II Trial of MAB Dose Escalation OF Bicalutamide For Biochemical Failure In Prostate Cancer Patients.
ClinicalTrials.gov Identifier: NCT00554086 - Recruiting
Prostate Cancer
- Bicalutamide in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00468715 - Recruiting
Breast Cancer
- Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003653 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003915 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer
- Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy
ClinicalTrials.gov Identifier: NCT00086736 - Completed
stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00430235 - Not yet recruiting
Adenocarcinoma of the Prostate
- Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00028769 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00005044 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
- Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002855 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004054 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00030654 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002633 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Hormone Therapy With or Without Mitoxantrone and Prednisone in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004124 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; ...
- SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
- Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
ClinicalTrials.gov Identifier: NCT00103376 - Recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Hormone Therapy in Treating Men With Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002651 - Recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant Therapy
ClinicalTrials.gov Identifier: NCT00418080 - Completed
Prostate Cancer
- Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
ClinicalTrials.gov Identifier: NCT00055731 - Recruiting
stage III prostate cancer; stage II prostate cancer
- Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00551044 - Completed
Prostatic Neoplasms
- Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00099086 - Recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003517 - Recruiting
adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Radiation Therapy With or Without Bicalutamide in Treating Patients With Stage II, Stage III, or Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002874 - Completed
stage II prostate cancer; stage III prostate cancer; recurrent prostate cancer
- Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide
ClinicalTrials.gov Identifier: NCT00421694 - Completed
Prostate Cancer
- Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00032006 - Completed
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; recurrent prostate cancer
- Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
ClinicalTrials.gov Identifier: NCT00023829 - Completed
stage III prostate cancer; stage II prostate cancer
Resources
- Bicalutamide (Drug Digest)
- Casodex (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
